Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Marloes G M DerksCornelis J H van de VeldeDaniele GiardielloCaroline SeynaeveHein PutterJohan W R NortierLuc Y DirixEsther BastiaannetJohanneke E A PortieljeGerrit-Jan LiefersPublished in: The oncologist (2019)
Older patients without comorbidity are at increased risk of dying from breast cancer, despite a higher other-cause mortality. This study shows that including age and comorbidity for the assessment of breast cancer mortality and other-cause mortality is indispensable for treatment decision making in older patients. Future prognostic tools for breast cancer prognosis should incorporate these items as well as risk of toxicity of adjuvant chemotherapy to adequately predict outcomes to optimize personalized treatment for older patients with early breast cancer.